Myelosclerosis with myeloid metaplasia
Myelosclerosis with myeloid metaplasia (also known as primary myelofibrosis or chronic idiopathic myelofibrosis) is a rare type of chronic leukemia characterized by the replacement of the bone marrow by fibrous (scar) tissue. This condition is part of a group of diseases called myeloproliferative disorders, which cause an increased production of blood cells.
Symptoms[edit | edit source]
The symptoms of myelosclerosis with myeloid metaplasia can vary greatly from person to person. Some people may have no symptoms at all, while others may experience fatigue, weakness, weight loss, and an enlarged spleen (splenomegaly). Other symptoms can include anemia, easy bruising or bleeding, and frequent infections.
Causes[edit | edit source]
The exact cause of myelosclerosis with myeloid metaplasia is unknown. However, it is believed to be related to mutations in certain genes, including the JAK2 gene. This condition is not inherited, but occurs as a result of these mutations.
Diagnosis[edit | edit source]
Diagnosis of myelosclerosis with myeloid metaplasia is often made through a combination of physical examination, blood tests, and bone marrow biopsy. Imaging tests such as CT scans or MRI may also be used to assess the size of the spleen and liver.
Treatment[edit | edit source]
Treatment for myelosclerosis with myeloid metaplasia is typically aimed at managing symptoms and improving quality of life. This can include medications to reduce spleen size, blood transfusions to treat anemia, and in some cases, stem cell transplantation.
Prognosis[edit | edit source]
The prognosis for individuals with myelosclerosis with myeloid metaplasia can vary greatly depending on the severity of the disease and the individual's overall health. Some people may live for many years with the disease, while others may have a more aggressive course.
See also[edit | edit source]
Myelosclerosis with myeloid metaplasia Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD